Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adagene, Aim Immunotech, Biontech, Brii, Iovance, Kaléo, Ossium Health, Pfizer, Shionogi, Sonnet, The AIDS Clinical Trials Group.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Foundation Medicine, Minute Molecular Diagnostics.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellcarta, Cruinn, Eurofins, Healthy.io, Jogo Health, Medica, Physiq, Rivaara, Sense Biodetection, Sirona Dx, Sphingotec, Ultivue.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytovale.

With global COVID-19 cases on the rise once again, the World Trade Organization (WTO) said it reached consensus among four WTO members – the U.S., European Union, India and South Africa – for an IP waiver regarding vaccines, a proposal to which biopharma reiterated its objections. Meanwhile, in the U.S., the White House appealed to Congress to provide adequate funding to continue the country’s pandemic response, and Pfizer Inc. and Biontech SE submitted an application to the FDA seeking emergency use authorization for a fourth shot of its COVID-19 vaccine.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allarity, Arrowhead, Beigene, Kairos, Maia, Medison, Myrtelle, Pepgen, Quoin, Wesana.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: APR, Betterlife, Biogen, Biotech Acquisiton, Blade, Boston Children’s Hospital, Catalyst, Clovis, Corium, Edigene, Evergreen, Hemogenyx, Kahr, Kempharm, Linkinvax, Nanomerics, Nospharm, Qualigen, Redhill, Relief, Sanofi, Seagen, Virpax.